452 related articles for article (PubMed ID: 18841250)
41. Prolonged effect of calcium supplementation on risk of colorectal adenomas in a randomized trial.
Grau MV; Baron JA; Sandler RS; Wallace K; Haile RW; Church TR; Beck GJ; Summers RW; Barry EL; Cole BF; Snover DC; Rothstein R; Mandel JS
J Natl Cancer Inst; 2007 Jan; 99(2):129-36. PubMed ID: 17227996
[TBL] [Abstract][Full Text] [Related]
42. Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Solomon SD; Pfeffer MA; McMurray JJ; Fowler R; Finn P; Levin B; Eagle C; Hawk E; Lechuga M; Zauber AG; Bertagnolli MM; Arber N; Wittes J;
Circulation; 2006 Sep; 114(10):1028-35. PubMed ID: 16943394
[TBL] [Abstract][Full Text] [Related]
43. The polyp prevention trial continued follow-up study: no effect of a low-fat, high-fiber, high-fruit, and -vegetable diet on adenoma recurrence eight years after randomization.
Lanza E; Yu B; Murphy G; Albert PS; Caan B; Marshall JR; Lance P; Paskett ED; Weissfeld J; Slattery M; Burt R; Iber F; Shike M; Kikendall JW; Brewer BK; Schatzkin A;
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1745-52. PubMed ID: 17855692
[TBL] [Abstract][Full Text] [Related]
44. Nonsteroidal anti-inflammatory drugs and aspirin for the prevention of colorectal adenomas and cancer: a systematic review.
Asano TK; McLeod RS
Dis Colon Rectum; 2004 May; 47(5):665-73. PubMed ID: 15054679
[TBL] [Abstract][Full Text] [Related]
45. Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas.
MacLennan R; Macrae F; Bain C; Battistutta D; Chapuis P; Gratten H; Lambert J; Newland RC; Ngu M; Russell A; Ward M; Wahlqvist ML;
J Natl Cancer Inst; 1995 Dec; 87(23):1760-6. PubMed ID: 7473832
[TBL] [Abstract][Full Text] [Related]
46. DFMO: targeted risk reduction therapy for colorectal neoplasia.
Laukaitis CM; Gerner EW
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):495-506. PubMed ID: 22122766
[TBL] [Abstract][Full Text] [Related]
47. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
48. A randomized, placebo-controlled trial of low-dose alpha-difluoromethylornithine in individuals at risk for colorectal cancer.
Love RR; Jacoby R; Newton MA; Tutsch KD; Simon K; Pomplun M; Verma AK
Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):989-92. PubMed ID: 9829706
[TBL] [Abstract][Full Text] [Related]
49. Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC; Ettrich T; Muche R; Wiedom M; Brockmöller J; Seeringer A; Seufferlein T
BMC Cancer; 2011 Aug; 11():360. PubMed ID: 21851602
[TBL] [Abstract][Full Text] [Related]
50. Colorectal adenomas in a randomized folate trial: the role of baseline dietary and circulating folate levels.
Figueiredo JC; Levine AJ; Grau MV; Barry EL; Ueland PM; Ahnen DJ; Byers T; Bresalier RS; Summers RW; Bond J; McKeown-Eyssen GE; Sandler RS; Haile RW; Baron JA
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2625-31. PubMed ID: 18843003
[TBL] [Abstract][Full Text] [Related]
51. Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
Logan RF; Grainge MJ; Shepherd VC; Armitage NC; Muir KR;
Gastroenterology; 2008 Jan; 134(1):29-38. PubMed ID: 18022173
[TBL] [Abstract][Full Text] [Related]
52. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study.
Shimizu M; Fukutomi Y; Ninomiya M; Nagura K; Kato T; Araki H; Suganuma M; Fujiki H; Moriwaki H
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3020-5. PubMed ID: 18990744
[TBL] [Abstract][Full Text] [Related]
53. Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.
Thompson PA; Ashbeck EL; Roe DJ; Fales L; Buckmeier J; Wang F; Bhattacharyya A; Hsu CH; Chow SH; Ahnen DJ; Boland CR; Heigh RI; Fay DE; Hamilton SR; Jacobs ET; Martinez EM; Alberts DS; Lance P
J Natl Cancer Inst; 2016 Dec; 108(12):. PubMed ID: 27530656
[TBL] [Abstract][Full Text] [Related]
54. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial.
Reid ME; Duffield-Lillico AJ; Sunga A; Fakih M; Alberts DS; Marshall JR
Int J Cancer; 2006 Apr; 118(7):1777-81. PubMed ID: 16217756
[TBL] [Abstract][Full Text] [Related]
55. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
[TBL] [Abstract][Full Text] [Related]
56. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
57. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
58. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
[TBL] [Abstract][Full Text] [Related]
59. An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis.
Lynch PM; Burke CA; Phillips R; Morris JS; Slack R; Wang X; Liu J; Patterson S; Sinicrope FA; Rodriguez-Bigas MA; Half E; Bulow S; Latchford A; Clark S; Ross WA; Malone B; Hasson H; Richmond E; Hawk E
Gut; 2016 Feb; 65(2):286-95. PubMed ID: 25792707
[TBL] [Abstract][Full Text] [Related]
60. Concomitant DFMO and sulindac chemoprevention of colorectal adenomas: a major clinical advance.
Sporn MB; Hong WK
Nat Clin Pract Oncol; 2008 Nov; 5(11):628-9. PubMed ID: 18725921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
